Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis.

MLA

Weeks, Kristin S., et al. “Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis.” Obstetrics & Gynecology International, Sept. 2020, pp. 1–12. EBSCOhost, https://doi.org/10.1155/2020/2374716.

APA

Weeks, K. S., Herbach, E., McDonald, M., Charlton, M., & Schweizer, M. L. (2020). Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis. Obstetrics & Gynecology International, 1–12. https://doi.org/10.1155/2020/2374716

Chicago

Weeks, Kristin S., Emma Herbach, Megan McDonald, Mary Charlton, and Marin L. Schweizer. 2020. “Meta-Analysis of VTE Risk: Ovarian Cancer Patients by Stage, Histology, Cytoreduction, and Ascites at Diagnosis.” Obstetrics & Gynecology International, September, 1–12. doi:10.1155/2020/2374716.